TY - JOUR
T1 - Participant understanding of informed consent in a multidisease community-based health screening and biobank platform in rural South Africa
AU - Vukuzazi team
AU - Ngwenya, Nothando
AU - Luthuli, Manono
AU - Gunda, Resign
AU - Gumede, Ntombizonke A.
AU - Adeagbo, Oluwafemi
AU - Nkosi, Busisiwe
AU - Gareta, Dickman
AU - Koole, Olivier
AU - Siedner, Mark
AU - Wong, Emily B.
AU - Seeley, Janet
AU - Surujdeen, Ashmika
AU - Khumalo, Hlolisile
AU - Mhlongo, Ngcebo
AU - Bucibo, Sanah
AU - Gumbi, Sibahle
AU - Mthembu, Lindani
AU - McHunu, Seneme
AU - Phakamani, Mkhwanazi
AU - Anele, Mkhwanazi
AU - Ntombiyenhlanhla, Mkhwanazi
AU - Rose, Myeni
AU - Mandlakayise, Zikhali
AU - Fezeka, Mfeka
AU - Hlobisile, Gumede
AU - Nozipho, Mbonambi
AU - Hloniphile, Ngubane
AU - Thokozani, Simelane
AU - Bongumenzi, Ndlovu
AU - Talente, Ntimbane
AU - Mbali, Mbuyisa
AU - Xolani, Mkhize
AU - Melusi, Sibiya
AU - Ntombela, Ntombiyenkosi
AU - Dlamini, Mandisi
AU - Nkosi, Thengokwakhe
AU - Mkhwanazi, Sibusiso
AU - Skhumbuzo, Mthombeni
AU - Hlobisile, Chonco
AU - Hlengiwe, Dlamini
AU - Doctar, Mlambo
AU - Nonhlanhla, Mzimela
AU - Zinhle, Buthelezi
AU - Mpumelelo, Steto
AU - Sibusiso, Mhlongo
AU - Bongani, Magwaza
AU - Siyabonga, Nsibande
AU - Nombuyiselo, Zondi
AU - Khanyisani, Buthelezi
AU - Sibusiso, Nsibande
N1 - Publisher Copyright:
© The Author(s) 2020. Published by Oxford University Press on behalf of Royal Society of Tropical Medicine and Hygiene. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.
PY - 2020/11/1
Y1 - 2020/11/1
N2 - Background: In low- and middle-income settings, obtaining informed consent for biobanking may be complicated by socio-economic vulnerability and context-specific power dynamics. We explored participants experiences and perceptions of the research objectives in a community-based multidisease screening and biospecimen collection platform in rural KwaZulu-Natal, South Africa. Methods: We undertook semi-structured in-depth interviews to assess participant understanding of the informed consent, research objectives and motivation for participation. Results: Thirty-nine people participated (individuals who participated in screening/biospecimen collection and those who did not and members of the research team). Some participants said they understood the information shared with them. Some said they participated due to the perceived benefits of the reimbursement and convenience of free healthcare. Most who did not participate said it was due to logistical rather than ethical concerns. None of the participants recalled aspects of biobanking and genetics from the consent process. Conclusions: Although most people understood the study objectives, we observed challenges to identifying language appropriate to explain biobanking and genetic testing to our target population. Engagement with communities to adopt contextually relevant terminologies that participants can understand is crucial. Researchers need to be mindful of the impact of communities’ socio-economic status and how compensation can be potentially coercive.
AB - Background: In low- and middle-income settings, obtaining informed consent for biobanking may be complicated by socio-economic vulnerability and context-specific power dynamics. We explored participants experiences and perceptions of the research objectives in a community-based multidisease screening and biospecimen collection platform in rural KwaZulu-Natal, South Africa. Methods: We undertook semi-structured in-depth interviews to assess participant understanding of the informed consent, research objectives and motivation for participation. Results: Thirty-nine people participated (individuals who participated in screening/biospecimen collection and those who did not and members of the research team). Some participants said they understood the information shared with them. Some said they participated due to the perceived benefits of the reimbursement and convenience of free healthcare. Most who did not participate said it was due to logistical rather than ethical concerns. None of the participants recalled aspects of biobanking and genetics from the consent process. Conclusions: Although most people understood the study objectives, we observed challenges to identifying language appropriate to explain biobanking and genetic testing to our target population. Engagement with communities to adopt contextually relevant terminologies that participants can understand is crucial. Researchers need to be mindful of the impact of communities’ socio-economic status and how compensation can be potentially coercive.
KW - Demographic surveillance
KW - Ethics
KW - Informed consent
KW - South Africa
UR - http://www.scopus.com/inward/record.url?scp=85095976975&partnerID=8YFLogxK
U2 - 10.1093/inthealth/ihaa072
DO - 10.1093/inthealth/ihaa072
M3 - Article
C2 - 33165556
AN - SCOPUS:85095976975
SN - 1876-3413
VL - 12
SP - 560
EP - 566
JO - International Health
JF - International Health
IS - 6
ER -